Gemcitabine vs Normal saline
Overall survival (absolute effect size estimates based on survival rate at 12 months) · patients with non‐muscle invasive bladder cancer
It is very uncertain whether gemcitabine changes time to death from any cause (absolute effect size estimates based… compared with saline (very low certainty).
1 finding from 1 review
- Intravesical gemcitabine for non‐muscle invasive bladder cancer 2021 · Cochrane Headline outcomes onlyHR 0.62 [0.39, 1]2 studies · 734 participantsVery low